Pathstone Family Office’s Johnson & Johnson JNJ Stock Holding History

Pathstone Family Office’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$36.3M	Buy	231,738 +145,667	+169%	+$24M	0.28%	59
2023 Q2	$14.1M	Buy	86,071 +1,325	+2%	+$214K	0.2%	80
2023 Q1	$12.9M	Sell	84,746 -175,764	-67%	-$28.4M	0.21%	81
2022 Q4	$36.1M	Buy	260,510 +60,581	+30%	+$10.5M	0.31%	60
2022 Q3	$33M	Buy	199,929 +154,772	+343%	+$26.2M	0.3%	55
2022 Q2	$8.02M	Buy	45,157 +22,001	+95%	+$3.92M	0.18%	78
2022 Q1	$4.29M	Buy	23,156 +85	+0.4%	+$14.5K	0.1%	96
2021 Q4	$3.95M	Sell	23,071 -1,443	-6%	-$236K	0.1%	106
2021 Q3	$3.96M	Sell	24,514 -402	-2%	-$68.6K	0.12%	92
2021 Q2	$4.11M	Buy	24,916 +4,396	+21%	+$728K	0.12%	89
2021 Q1	$3.37M	Buy	20,520 +10,808	+111%	+$1.75M	0.11%	89
2020 Q4	$1.53M	Buy	9,712 +5,460	+128%	+$806K	0.06%	100
2020 Q3	$632K	Buy	4,252 +113	+3%	+$16.7K	0.07%	106
2020 Q2	$583K	Sell	4,139 -977	-19%	-$142K	0.07%	99
2020 Q1	$673K	Buy	5,116 +1,242	+32%	+$176K	0.1%	91
2019 Q4	$5.65M	Sell	3,874 -359	-8%	-$48.7K	0.06%	97
2019 Q3	$548K	Sell	4,233 -6,893	-62%	-$908K	0.07%	88
2019 Q2	$1.55M	Buy	11,126 +398	+4%	+$55.1K	0.18%	60
2019 Q1	$1.5M	Buy	10,728 +5,185	+94%	+$695K	0.19%	56
2018 Q4	$715K	Buy	5,543 +2,115	+62%	+$295K	0.21%	42
2018 Q3	$473K	Sell	3,428 -150	-4%	-$19.9K	0.15%	38
2018 Q2	$434K	Sell	3,578 -263	-7%	-$32.8K	0.32%	30
2018 Q1	$492K	Buy	3,841 +61	+2%	+$8.24K	0.27%	33
2017 Q4	$529K	Sell	3,780 -9	-0.2%	-$1.25K	0.29%	22
2017 Q3	$492K	Sell	3,789 -3,400	-47%	-$451K	0.44%	27
2017 Q2	$951K	Sell	7,189 -89	-1%	-$11.4K	0.4%	30
2017 Q1	$907K	Sell	7,278 -774	-10%	-$92.5K	0.5%	25
2016 Q4	$928K	Buy	8,052 +4,767	+145%	+$551K	0.59%	21
2016 Q3	$387K	Hold	3,285	–	–	0.4%	20
2016 Q2	$398K	Hold	3,285	–	–	0.38%	18
2016 Q1	$355K	Buy	+3,285	New	+$340K	0.72%	19
2015 Q2	–	Sell	-644	Closed	-$65K	–	134
2015 Q1	$65K	Hold	644	–	–	0.1%	34
2014 Q4	$67K	Sell	644 -1,002	-61%	-$106K	0.23%	25
2014 Q3	$176K	Buy	1,646 +502	+44%	+$52.1K	0.55%	13
2014 Q2	$119K	Hold	1,144	–	–	0.34%	12
2014 Q1	$112K	Hold	1,144	–	–	0.29%	15
2013 Q4	$105K	Buy	1,144 +415	+57%	+$38.2K	0.23%	20
2013 Q3	$63K	Sell	729 -1,001	-58%	-$89.8K	0.27%	59
2013 Q2	$148K	Buy	+1,730	New	+$147K	0.17%	33

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pathstone Family Office's JNJ Position: Q3 2023 in Review

Pathstone Family Office increased its Johnson & Johnson (JNJ) stake by 169% in Q3 2023, buying an estimated $24M and bringing the position to 231,738 shares worth $36.3M. The position accounts for 0.28% of the portfolio, ranked #59.

Pathstone Family Office first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

Pathstone Family Office held 231,738 shares of Johnson & Johnson worth $36.3M as of Q3 2023.
Pathstone Family Office bought 145,667 Johnson & Johnson shares in Q3 2023, an estimated $24M.
Johnson & Johnson made up 0.28% of Pathstone Family Office's portfolio in Q3 2023, its #59 holding.
Pathstone Family Office first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.